Graegis Pharmaceuticals Limited is a private limited company located at C/O The Cambridge Partnership The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge CB22 3FH. Incorporated on 2021-10-14, this 2-year-old company is run by 1 director.
Director Thibaud P., appointed on 01 December 2021.
The company is officially classified as "research and experimental development on biotechnology" (SIC: 72110).
The latest confirmation statement was sent on 2023-10-13 and the due date for the following filing is 2024-10-27. Furthermore, the accounts were filed on 31 October 2022 and the next filing should be sent on 30 September 2024.
Office Address | C/o The Cambridge Partnership The Dorothy Hodgkin Building |
Office Address2 | Babraham Research Campus |
Town | Cambridge |
Post code | CB22 3FH |
Country of origin | United Kingdom |
Registration Number | 13680871 |
Date of Incorporation | Thu, 14th Oct 2021 |
Industry | Research and experimental development on biotechnology |
End of financial Year | 31st December |
Company age | 3 years old |
Account next due date | Mon, 30th Sep 2024 (144 days left) |
Account last made up date | Mon, 31st Oct 2022 |
Next confirmation statement due date | Sun, 27th Oct 2024 (2024-10-27) |
Last confirmation statement dated | Fri, 13th Oct 2023 |
The list of PSCs who own or have control over the company is made up of 4 names. As we researched, there is Clevexel Pharma from Paris, France. This PSC is categorised as "a simplified joint stock company (société par actions simplifiée)", has 25-50% voting rights and has 25-50% shares. This PSC has 25-50% voting rights and has 25-50% shares. The second entity in the persons with significant control register is Medicxi Iii Lp that entered Jersey, Jersey as the official address. This PSC has a legal form of "a limited partnership", owns 25-50% shares. This PSC owns 25-50% shares. The third one is Clevexel Pharma, who also meets the Companies House requirements to be listed as a person with significant control. This PSC has a legal form of "a simplified joint stock company (société par actions simplifiée)", owns 25-50% shares. This PSC , owns 25-50% shares.
Clevexel Pharma
19 Avenue D'Italie, Paris, 75013, France
Legal authority | French Law |
Legal form | Simplified Joint Stock Company (Société Par Actions Simplifiée) |
Country registered | France |
Place registered | Paris Commercial Registry |
Registration number | 790 115 026 |
Notified on | 1 August 2023 |
Ceased on | 14 October 2023 |
Nature of control: |
25-50% voting rights 25-50% shares |
Medicxi Iii Lp
44 Esplanade, St Helier, Jersey, JE4 9WG, Jersey
Legal authority | Companies (Jersey) Law |
Legal form | Limited Partnership |
Country registered | Jersey |
Place registered | Jersey |
Registration number | 2938 |
Notified on | 1 December 2021 |
Ceased on | 14 October 2023 |
Nature of control: |
25-50% shares |
Clevexel Pharma
19 Avenue D'Italie, Paris, 75013, France
Legal authority | French Law |
Legal form | Simplified Joint Stock Company (Société Par Actions Simplifiée) |
Country registered | France |
Place registered | Paris Commercial Registry |
Registration number | 790 115 026 |
Notified on | 20 December 2021 |
Ceased on | 1 August 2023 |
Nature of control: |
25-50% shares |
Richard L.
Notified on | 14 October 2021 |
Ceased on | 1 December 2021 |
Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
Type | Category | Free download | |
---|---|---|---|
RESOLUTIONS |
Resolution adopting the Articles of Association filed on: 6th, November 2023 |
resolution | Free Download (2 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy